Nutrient-Delivery and Metabolism Reactivation Therapy for Melanoma. Yang Chen et al.
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
Nutrient-Delivery and Metabolism Reactivation Therapy for Melanoma
应用场景：
创建时间：
2023-10-05
相关数据集
Fecal microbiota transplantation and its repercussions in patients with melanoma refractory to anti-PD-1 therapy: scope review
ABSTRACT Introduction: despite being extremely effective in some cases, up to 70% of patients with melanoma do not respond to anti-PD-1/PD-L1 (primary resistance) and many of the responders eventually
DataCite Commons2023-05-20 更新110
Supplementary Tables – Treatment Patterns and Outcomes following Disease Progression on Anti-PD-1 Therapies for Advanced Melanoma
Supplemental Table 1. Treatment Patterns after Index Line for the Anti-programmed Cell Death-1-treated Patients with Advanced Melanoma Treated with a BRAF Therapy in the Index Line or Pri
DataCite Commons2024-02-14 更新90
Supplementary Material for: Characterization and Outcomes of Disease Progression in 52 Patients Treated with BRAF -V600 + MEK Inhibitors for Advanced Melanoma
Background: Combined treatment with BRAF -V600 and MEK inhibitors has significantly improved progression-free and overall survival of patients with BRAF -mutated melanoma. Pa
DataCite Commons2020-08-28 更新70
Source-data Johann et al..xlsx
Therapeutic melanoma inhibition by local micelle-mediated cyclic nucleotide repression Source data underlying Figures and Supplementary Figures
DataCite Commons2021-08-19 更新90
Synthetic lethal screening with small molecule inhibitors provides a pathway to rational combination therapies for melanoma
Recent data demonstrate that extracellular signals are transmitted through a network of proteins rather than hierarchical signaling pathways. This network model suggests why inhibition of a single com
NIAID Data Ecosystem70
